Disease-Specific Advocacy Groups Appeal To Congress For R&D Funding

CQ Weekly: Dueling Diseases: The Race for Cure Dollars
“…As Congress assembles its budgets and spending bills, patient advocacy groups for specific diseases issue public pleas for more money for medical research — nothing as unseemly as earmarks or carve-outs, but general support for the National Institutes of Health and other politically popular health causes that tend to foment bipartisan comity. … Behind the scenes, however, the veneer of collegiality that these groups display during their rounds on Capitol Hill is cracking. Groups are jockeying to prioritize their particular diseases and stay on offense, anticipating that tight budgets brought about by the budget sequester could force lawmakers to choose between spending on Alzheimer’s and HIV/AIDS or squelch funding for some promising line of cures…” (Attias, 6/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.